Michael A. Curran

Dr. Curran is an Assistant Professor of Immunology at The University of Texas MD Anderson Cancer Center. He is scientific director of the Oncology Research for Biologics and Immunotherapy Translation (ORBIT) platform, which coordinates development and production of clinical immunotherapeutic antibodies based on novel targets and preclinical reagents originating at MD Anderson. He also heads an independent laboratory at MD Anderson, where his group studies the origins of the immunosuppressive tumor microenvironment and how it can be disrupted to facilitate immune-mediated tumor rejection.

Dr. Curran completed B.A. degrees in biology and foreign affairs and a minor in computer science at the University of Virginia and received a PhD in immunology from Stanford University. Dr. Curran completed his postdoctoral studies in the laboratory of James P. Allison, PhD, where he was the first recipient of the prestigious American Cancer Society Levy Fellowship. He is also a recipient of the Society for Immunotherapy of Cancer’s prestigious Presidential Award.